MIM
XERS icon

Monashee Investment Management’s Xeris Biopharma Holdings XERS Stock Holding History

Monashee Investment Management’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-350,000
Closed -$931K – 264
2020
Q2 		$931K Buy
+350,000
New +$1.22M 0.14% 133
2019
Q2 		– Sell
-100,000
Closed -$1M – 197
2019
Q1 		$1M Buy
+100,000
New +$1.28M 0.23% 95
2018
Q2 		– Hold
0
– – – 56

Other funds holding XERS

SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Deltec Asset Management New York $545M AUM 33.4% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Monashee Investment Management's XERS Position: Q3 2020 in Review

Monashee Investment Management sold out of Xeris Biopharma Holdings (XERS) in Q3 2020, closing a stake of 350,000 shares — an estimated $931K sold.

Monashee Investment Management first reported a position in XERS in Q1 2019 and held it in 2 quarters. The position peaked at $1M in Q1 2019. 86 funds tracked by Wall St. Rank hold XERS as of Q3 2020.

  • Monashee Investment Management reported no remaining Xeris Biopharma Holdings position as of Q3 2020 after selling out during the quarter.
  • Monashee Investment Management sold 350,000 Xeris Biopharma Holdings shares in Q3 2020, an estimated $931K.
  • Monashee Investment Management first reported a position in Xeris Biopharma Holdings in Q1 2019 and held it in 2 quarters.
  • Monashee Investment Management's Xeris Biopharma Holdings position peaked at $1M in Q1 2019.
  • 86 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q3 2020.

Based on Monashee Investment Management's 13F filing for Q3 2020, filed 13 Nov 2020.